Immunological implications of the use of plant lectins for drug and vaccine targeting to the gastrointestinal tract

Journal of Drug Targeting

Volumn 12, Issue 2, 2004, Pages 89-95

  Lavelle, E C ^a   Grant, G ^b   Pfuller, U ^c   O'Hagan, D T ^d  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adjuvant; Drug delivery; Mistletoe lectin; Plant lectin; Targeting; Type 2 RIP

Indexed keywords

AGGLUTININ; LIPOSOME; OVALBUMIN; PLANT LECTIN; TOMATO AGGLUTININ; UNCLASSIFIED DRUG; VACCINE; VISCUM ALBUM LECTIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG TARGETING; FEMALE; GASTROINTESTINAL TRACT; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOMATO;

ADMINISTRATION, ORAL; ANIMALS; DRUG DELIVERY SYSTEMS; FEMALE; GASTROINTESTINAL TRACT; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PLANT LECTINS; PLANT PREPARATIONS; PLANT PROTEINS; TOXINS, BIOLOGICAL; VACCINES;

EID: 2942724579     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10611860410001693733     Document Type: Article

References (33)

1. Agapov, I.I., Tonevitsky, A.G., Moysenovich, M.M., Maluchemko, N.V., Weyhenmeyer, R. and Kirpichnikov, M.P. (1999) "Mistletoe lectin dissociates into catalytic and binding subunits before translocation across the membrane to the cytoplasm", FEBS Lett. 452, 211-214.
2. Barbieri, L., Valbonesi, P., Gorini, P., Pession, A. and Stirpe, F. (1996) "Polynucleotide: adenosine glycosidase activity of saporin-L1: effect on DNA, RNA and poly (A)", Biochem. J, 319, 507-513.
3. Berzofsky, J.A., Ahlers, J.D. and Belyakov, I.M. (2001) "Strategies for designing and optimizing new generation vaccines", Nat. Rev. Immunol. 1, 209-219.
4. Bussing, A., Stein, G.M., Pfuller, U. and Schnietzel, M. (1999) "Differential binding of toxic lectins from Viscum album L., MLI and MLIII, to human lymphocytes", Anticancer Res. 19, 5095-5099.
5. Chen, H., Torchilin, V. and Langer, R. (1996) "Lectin-bearing polymerized liposomes as potential oral vaccine carriers", Pharm. Res. 13, 1378-1383.
6. Damgé, C., Michel, C., Aprahamian, M., Couvreur, P. and Devissaguet, J.P. (1990) "Nanocapsules as carriers for oral peptide delivery", J. Control. Release 13, 233-239.
7. De Aizpurua, H.J.D. and Russell-Jones, G.L. (1988) "Identification of classes of proteins that provide an immune response upon oral feeding", J. Exp. Med. 167, 440-451.
8. Florence, A.T., Hillery, A.M., Hussain, N. and Jani, P.U. (1995) "Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate", J. Control. Release 36, 39-46.
9. Foster, N., Clark, M.A., Jepson, M.A. and Hirst, B.H. (1998) "Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo", Vaccine 16, 536-541.
10. Franz, H., Ziska, P. and Kindt, A. (1981) "Isolation and properties of three lectins from mistletoe (Viscum album L.)", Biochem. J. 195, 481-484.
11. Gabor, F., Stangl, M. and Wirth, M. (1995) "Lectin-mediated bioadhesion: binding characteristics of plant lectins on the enterocyte-like cell lines Caco-2, HT-29 and HCT-8", J. Control. Release 55, 131-142.
12. Giannasca, P.J., Boden, J.A. and Monath, T.P. (1997) "Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell directed lectins", Infect. Immun. 65, 4288-4298.
13. Jäggy, C., Musielski, H., Urech, K. and Schaller, G. (1995) "Quantitative determination of lectins in mistletoe preparations", Drug Res. 45, 905-909.
14. Jung, T., Kamm, W., Breitenbach, A., Kaiserling, E., Xiao, J.X. and Kissel, T. (2000) "Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?", Eur. J. Pharm. Biopharm. 50, 147-160.
15. Koshte, V.L., Aalbers, M., Calkhoven, P.G. and Aalberse, R.C. (1992) "The potent IgG4 - inducing antigen in banana is a mannose-binding lectin, BanLec-1", Int. Arch. Allergy Appl. Immunol. 97, 17-24.
16. Lavelle, E.C. (2001) "Targeted delivery of drugs to the gastrointestinal tract", Crit. Rev. Ther. Drug Carrier Syst. 18, 341-386.
17. Lavelle, E.C., Grant, G., Pusztai, A., Pfüller, U. and O'Hagan, D.T. (2000) "Mucosal immunogenicity of plant lectins in mice", Immunology 99, 30-37.
18. Lavelle, E.C., Grant, G., Pusztai, A., Pfüller, U. and O'Hagan, D.T. (2001) "The identification of plant lectins with mucosal adjuvant activity", Immunology 102, 77-86.
19. Lavelle, E.C., Grant, G., Pusztai, A., Pfüller, U., Leavy, O., McNeela, E. and O'Hagan, D.T. (2002) "Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2", Immunology 107, 268-274.
20. Lee, R.T., Gabius, H.J. and Lee, Y.C. (1994) "The sugar-combining area of the galactose-specific toxic lectin of mistletoe extends beyond the terminal sugar residue: comparison with a homologous toxic lectin, ricin", Carbohydr. Res. 254, 269-276.
21. Muthing, J., Burg, M., Mockel, B., Langer, M., Metelmann-Strupat, W., Werner, A., Neumann, U., Peter-Katalinic, J. and Eck, J. (2002) "Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally alpha2-6-sialylated neolacto-series gangliosides", Glycobiology 12, 485-497.
22. Naisbett, B. and Woodley, J. (1995) "The potential use of tomato lectin for oral drug delivery: 4. Immunological consequences" , Int. J. Pharm. 120, 247-254.
23. Niwa, H., Tonevitsky, A.G., Agapov, I.I., Saward, S., Pfuller, U. and Palmer, R.A. (2003) "Crystal structure at 3 A of mistletoe lectin I, a dimeric type-II ribosome-inactivating protein, complexed with galactose", Eur. J. Biochem. 270, 2739-2749.
24. O'Hagan, D.T. (1998) "Microparticles and polymers for the mucosal delivery of vaccines", Adv. Drug Deliv. Rev. 34, 305-320.
25. Peumans, W.J., Hao, Q. and Van Damme, E.J. (2001) "Ribosome-inactivating proteins from plants: more than RNA N-glycosidases?", FASEB J. 15, 1493-1506.
26. Pfüller, U. (2000) "Chemical constituents of European mistletoe (Viscum album L.). Isolation and characterisation of the main relevant ingredients: lectins, viscotoxins, oligo-/polysaccharides, flavonoides", In: Büssing, A., ed., Mistletoe. The Genus Viscum (Harwood Academic Publishers, Amsterdam), pp 101-122.
27. Russell-Jones, G.J. (2001) "The potential of receptor-mediated endocytosis for oral drug delivery", Adv. Drug Deliv. Rev. 1, 59-73.
28. Sandvig, K. and van Deurs, B. (1996) "Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin", Physiol. Rev. 76, 949-966.
29. Sharma, R., van Damme, E.J., Peumans, W.J., Sarsfield, P. and Schumacher, U. (1996) "Lectin binding reveals divergent carbohydrate expression in human and mouse Peyer's patches", Histochem. Cell. Biol. 105, 459-465.
30. Szabo, S.J., Sullivan, B.M., Peng, S.L. and Glimcher, L.H. (2003) "Molecular mechanisms regulating Th1 immune responses", Annu. Rev. Immunol. 21, 713-758.
31. Ugozzoli, M., Santos, G., Donnelly, J. and O'Hagan, D.T. (2001) "Potency of a genetically detoxified mucosal adjuvant derived from the heat-labile enterotoxin of Escherichia coli (LTK63) is not adversely affected by the presence of preexisting immunity to the adjuvant", J. Infect. Dis. 183, 351-354.
32. Van Damme, E.J.M., Hao, Q., Charels, D., Barre, A., Rougé, P. and Van Leuven, F. (2000) "Characterization and molecular cloning of two different type 2 ribosome-inactivating proteins from the monocotyledonous plant Polygonatum multiflorum", Eur. J. Biochem. 267, 2746-2749.
33. Wirth, M., Hamilton, G. and Gabor, F. (1998) "Lectin-mediated drug targeting: quantification of binding and internalization of Wheat germ agglutinin and Solanum tuberosum lectin using Caco-2 and HT-29 cells", J. Drug Target. 6, 95-104.